ClinicalTrials.Veeva

Menu
N

North Texas Infectious Diseases Consultants | Downtown Dallas Office

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

TAF
Emtricitabine
TDF
Tenofovir Alafenamide
FTC
RPV
Lenacapavir
Bictegravir
Tenofovir Disoproxil Fumarate
Rilpivirine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 17 total trials
Locations recently updated

ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

This clinical trial is designed to compare the efficacy and safety of Clofazimine Inhalation Suspension versus placebo when added to guideline-based...

Enrolling
Mycobacterium Infections, Nontuberculous
MAC Lung Disease
Drug: Placebo
Drug: Clofazimine Inhalation Suspension
Status recently updated

This study is part of a master study. The goal of master protocol (GSUS-544-5905, NCT05585307) is to learn how novel antiretrovirals (medicines that...

Enrolling
Active, not recruiting
HIV-1-infection
Drug: BVY
Drug: GS-1219

The goal of this clinical study is to learn about the safety and efficacy of switching to once weekly tablet of islatravir/lenacapavir (ISL/LEN) regi...

Active, not recruiting
HIV-1-infection
Drug: B/F/TAF
Drug: PTM ISL/LEN

The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC) plus lenacapavir (LEN), versus...

Active, not recruiting
HIV-1-infection
Drug: Stable Baseline Regimen
Drug: Bictegravir

Trial sponsors

Gilead Sciences logo
Janssen (J&J Innovative Medicine) logo
Janssen (J&J Innovative Medicine) logo
BioNTech logo
Janssen (J&J Innovative Medicine) logo
MannKind logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems